Skip to main navigation Skip to search Skip to main content

The connexin hemichannel inhibitor D4 produces rapid antidepressant-like effects in mice

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

57 Downloads (CityUHK Scholars)

Abstract

Depression is a common mood disorder characterized by a range of clinical symptoms, including prolonged low mood and diminished interest. Although many clinical and animal studies have provided significant insights into the pathophysiology of depression, current treatment strategies are not sufficient to manage this disorder. It has been suggested that connexin (Cx)-based hemichannels are candidates for depression intervention by modifying the state of neuroinflammation. In this study, we investigated the antidepressant-like effect of a recently discovered selective Cx hemichannel inhibitor, a small organic molecule called D4. We first showed that D4 reduced hemichannel activity following systemic inflammation after LPS injections. Next, we found that D4 treatment prevented LPS-induced inflammatory response and depressive-like behaviors. These behavioral effects were accompanied by reduced astrocytic activation and hemichannel activity in depressive-like mice induced by repeated low-dose LPS challenges. D4 treatment also reverses depressive-like symptoms in mice subjected to chronic restraint stress (CRS). To test whether D4 broadly affected neural activity, we measured c-Fos expression in depression-related brain regions and found a reduction in c-Fos+ cells in different brain regions. D4 significantly normalized CRS-induced hypoactivation in several brain regions, including the hippocampus, entorhinal cortex, and lateral septum. Together, these results indicate that blocking Cx hemichannels using D4 can normalize neuronal activity and reduce depressive-like symptoms in mice by reducing neuroinflammation. Our work provides evidence of the antidepressant-like effect of D4 and supports glial Cx hemichannels as potential therapeutic targets for depression. © The Author(s) 2023.
Original languageEnglish
Article number191
JournalJournal of Neuroinflammation
Volume20
Online published20 Aug 2023
DOIs
Publication statusPublished - 2023

Funding

This work was partially supported by the Shenzhen General Basic Research Program JCYJ20190808182203591 (to CGL), Hong Kong Research Grants Council RGC/ECS 21103818 and RGC/GRF 11104320 and 11104521 (to CGL), internal funds from City University of Hong Kong (to CGL), two Grants from the Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) 1231523 (to JCS) and 3210284 (to MS), and a Grant ICM-ANID, Project P09-022 from the Centro Interdisciplinario de Neurociencia de Valparaíso (to JCS).

Research Keywords

  • Antidepressant
  • Connexin hemichannels
  • Depression
  • Glia
  • Stress

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

RGC Funding Information

  • RGC-funded

Fingerprint

Dive into the research topics of 'The connexin hemichannel inhibitor D4 produces rapid antidepressant-like effects in mice'. Together they form a unique fingerprint.

Cite this